Cutaneous reactions due to diltiazem and cross reactivity with other calcium channel blockers

Allergologia et Immunopathologia

Volumn 33, Issue 4, 2005, Pages 238-240

  Gonzalo Garijo, M A ^a   Perez Calderon R ^a   De Argila Fernandez Duran, D ^a   Rangel Mayoral, Juan Francisco ^a  

^a HOSPITAL INFANTA CRISTINA   (Spain)

Author keywords

Calcium channel blockers; Cross reactions; Delayed hypersensitivity; Diltiazem; Patch tests

Indexed keywords

AMLODIPINE; ANTIHISTAMINIC AGENT; BENZOTHIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; EMOLLIENT AGENT; LACIDIPINE; LERCANIDIPINE; NICARDIPINE; NIFEDIPINE; NIMODIPINE; NITRENDIPINE; PHENYLALKYLAMINE; STEROID; VERAPAMIL;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; CROSS REACTION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHEMA; ERYTHEMA MULTIFORME; ERYTHRODERMA; EXFOLIATIVE DERMATITIS; FEMALE; HUMAN; HYPERSENSITIVITY REACTION; MALE; PATCH TEST; PRURITUS; RASH; REMISSION; SKIN EXFOLIATION; SKIN MANIFESTATION;

EID: 26944500594     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: 10.1157/13077752     Document Type: Article

References (13)

1. Stern R, Khalsa JH. Cutaneous adverse reactions associated with calcium channel blockers. Arch Intern Med. 1989;149:829-32.
2. Kitamura K, Kanasashi M, Suga C, Saito S, Yoshida S, Ikezawa Z. Cutaneous reactions induced by calcium channel blocker: high frequency of psoriasiform eruptions. J Dermatol. 1993;20:279-86.
3. Knowles S, Gupta AK, Shear NH. The spectrum of cutaneous reactions associated with diltiazem: three cases and a review of the literature. J Am Acad Dermatol. 1998;38(2 Pt 1):201-6.
4. Cholez C, Trechot P, Schmutz JL, Faure G, Bene MC, Barbaud A. Maculopapular rash induced by diltiazem: allergological investigations in four patients and cross reactions between calcium channel blockers. Allergy. 2003;58:1207-9.
5. Barbaud A, Trechot P, Gillet-Terver MN, Zannad F, Schmutz JL. Investigations immunoallergologiques dans une toxicodermie au diltiazem (Tildiem 300 LP). Therapie. 1993;48:499-500.
6. Baker BA, Cacchione JG. Dermatologic cross-sensitivity between diltiazem and amlodipine. Ann Pharmacother. 1994;28:118-9.
7. Sousa-Basto A, Azenha A, Duarte ML, Pardal-Oliveira F. Generalized cutaneous reaction to diltiazem. Contact Dermatitis. 1993;29:44-5.
8. Romano A, Pietrantonio F, Garcovich A, Rumi C, Bellocci F, Caradonna P, Barone C. Delayed hypersensitivity to diltiazem in two patients. Ann Allergy. 1992;69:31-2.
9. Jan V, Machet L, Gironet N, Martin L, Machet MC, Lorette G, Vaillant L. Acute generalized exanthematous pustulosis induced by diltiazem: value of patch testing. Dermatology. 1998;197:274-5.
10. Vicente-Calleja JM, Aguirre A, Landa N, Crespo V, Gonzalez-Perez R. Acute generalized exanthematous pustulosis due to diltiazem: confirmation by patch testing. Br J Dermatol. 1997;137:837-9.
11. Wakelin S, James M. Diltiazem-induced acute generalised exanthematous pustulosis. Clin Exp Dematol. 1995;20:341-4.
12. Kuo M, Winiarski N, Garella S. Nonthrombocytopenic purpura associated sequentially with nifedipine and diltiazem. Ann Pharmacother. 1992;26:1089-90.
13. Barbaud A, Gonçalo M, Bruynzeel D, Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis. 2001;45:321-8.